izvor podataka: crosbi
!
Efficacy and safety of biosimilar infliximab (Inflectra) in patients with ankylosing spondylitis: multicentre and observational one year follow-up study (CROSBI ID 250227)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
F. Grubisic, S. Grazio, B. Anic, M. Baresic, S. Novak, F. Anic, V. Prus, A. G. Gracanin, J. Morovic Vergles, D.M. Kaliterna, K. Boric, T. Kehler
Efficacy and safety of biosimilar infliximab (Inflectra) in patients with ankylosing spondylitis: multicentre and observational one year follow-up study // International Journal of Rheumatic Diseases, 20 (2017), 1; 51-51
Podaci o odgovornosti
F. Grubisic, S. Grazio, B. Anic, M. Baresic, S. Novak, F. Anic, V. Prus, A. G. Gracanin, J. Morovic Vergles, D.M. Kaliterna, K. Boric, T. Kehler
engleski
Efficacy and safety of biosimilar infliximab (Inflectra) in patients with ankylosing spondylitis: multicentre and observational one year follow-up study
The aim of the study was to evaluate the efficacy and safety of biosimilar Inflectra in patients with AS.
(biosimilar, infliximab, ankylosing spondylitis)
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Kliničke medicinske znanosti
Indeksiranost
